Skip to main content
OpenTrials
Completed

NCT Number: NCT00720915

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hamilton General Hospital, Hamilton, Ontario, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be >= 18 years of age
  • Have had ONE episode of unprovoked proximal DVT and/or PE
  • Have completed 3 uninterrupted months of warfarin therapy (target INR of 2.0-3.0)

Exclusion criteria

  • Another indication for long-term anticoagulation (e.g., atrial fibrillation)
  • A high risk of bleeding as evidenced by any of the following:
  • Age greater than 75 years
  • Previous episode of major bleeding where the cause was not effectively treated
  • Known chronic thrombocytopenia with a platelet count of less than 120,000 x 10^9 /L
  • Known chronic renal impairment with a creatinine of more than 150 mumols /litre (1.7 mg/dl)
  • Known chronic liver disease with a total bilirubin of more than 25 mumols /litre (1.5 mg/dl)
  • Active peptic ulcer disease
  • Poor compliance with, or control of, anticoagulant therapy during initial treatment
  • Requires dual antiplatelet therapy (e.g. aspirin and clopidogrel)
  • A vena caval filter
  • Has had D-dimer testing performed within 2 months of potential enrollment other than for evaluation of suspected recurrent VTE that was not confirmed
  • Has a life expectancy less than 5 years
  • Is unable to attend follow-up visits because of geographic inaccessibility
  • Is participating in a competing clinical investigation

Treatment and study plan

Discontinue anticoagulant therapy (Negative d-dimer)

Other

Patients with negative d-dimer discontinue long-term anticoagulant therapy.

Continue on anticoagulant therapy (positive d-dimer)

Other

Patients with positive d-dimer continue or re-start on anticoagulant therapy

Primary outcomes

  1. Suspected Recurrent DVT

    Time frame: up to 7 years

  2. Suspected (recurrent) pulmonary embolism

    Time frame: up to 7 years

  3. Bleeding

    Time frame: up to 7 years

  4. Death

    Time frame: up to 7 years

Sponsors and collaborators

Lead sponsor

McMaster University

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)

Registry information

Official study title

A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing

Acronym: DODS

Important dates

Study start
2008
Primary completion
2016
Study completion
2016
First posted
Jul 23, 2008
Registry last updated
Dec 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.